Catherine Schulte Maintained (TMO) at Buy with Increased Target to $264 on, Oct 25th, 2018
Catherine has made no other calls on TMO in the last 4 months.
There are 3 other peers that have a rating on TMO. Out of the 3 peers that are also analyzing TMO, 1 agrees with Catherine's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Matthew Sykes of "Goldman Sachs" Downgraded from Strong Buy to Hold on, Monday, September 17th, 2018
These are the ratings of the 2 analyists that currently disagree with Catherine
- Daniel Arias of "Citigroup" Maintained at Strong Buy with Increased Target to $280 on, Wednesday, October 10th, 2018
- Jack Meehan of "Barclays" Maintained at Buy with Increased Target to $275 on, Monday, September 24th, 2018
on: Wed, Oct 10th 2018
by: WOPRAI
Daniel Arias Maintained (TMO) at Strong Buy with Increased Target to $280 on, Oct 10th, 2018
on: Wed, Oct 10th 2018
by: WOPRAI
Steve Beuchaw Maintained (TMO) at Buy with Increased Target to $254 on, Oct 10th, 2018
on: Mon, Oct 01st 2018
by: WOPRAI
Tristan Gerra Downgraded (AMD) to Hold and Increased Target to $28 on, Oct 1st, 2018
on: Fri, Oct 27th 2017
by: WOPRAI
Sumant Kulkarni Initiated (BIIB) at Hold and Held Target at $340 on, Oct 27th, 2017
on: Wed, Oct 25th 2017
by: WOPRAI
Carter Gould Maintained (BIIB) at Hold with Increased Target to $318 on, Oct 25th, 2017
on: Wed, Oct 25th 2017
by: WOPRAI
on: Wed, Oct 24th 2018
by: WOPRAI
Jack Meehan Maintained (WAT) at Hold with Decreased Target to $190 on, Oct 24th, 2018
on: Tue, Oct 23rd 2018
by: WOPRAI
Blayne Curtis Upgraded (AMD) to Hold and Held Target at $25 on, Oct 23rd, 2018
on: Mon, Oct 01st 2018
by: WOPRAI
Blayne Curtis Maintained (AMD) at Sell with Increased Target to $25 on, Oct 1st, 2018
on: Mon, Sep 24th 2018
by: WOPRAI
Jack Meehan Maintained (TMO) at Buy with Increased Target to $275 on, Sep 24th, 2018
on: Thu, Nov 09th 2017
by: WOPRAI
Jay Olson Initiated (BIIB) at Buy and Held Target at $350 on, Nov 9th, 2017
on: Mon, Nov 06th 2017
by: WOPRAI
Ian Somaiya Maintained (BIIB) at Buy with Increased Target to $386 on, Nov 6th, 2017
